Christopher J. Rhodes, PhD

Christopher J. Rhodes, PhD

Dr. Chris Rhodes has had over 30 years’ experience in diabetes and obesity research, mostly focused on the key role of the pancreatic beta-cell during the pathogenesis of both type-1 and -2 diabetes. He trained at the University of London, Joslin Diabetes Center and the University of Cambridge. He then had faculty positions at the Joslin Diabetes Center/Harvard Medical School, the University of Texas Southwestern Medical School at Dallas, the Pacific Northwest Research Institute and Department of Pharmacology at the University of Washington in Seattle. In the summer of 2006, Dr. Rhodes was recruited to the University of Chicago as Research Director of the newly formed Kovler Diabetes Center, Professor in the Department of Medicine and Chair of the Committee on Molecular Metabolism and Nutrition. In 2012 he was also appointed Chair of the Biomedical Cluster, a program overseeing >150 graduate student education. In July 2015, he retired from the University of Chicago to become Vice President for Cardiovascular and Metabolic Disease Research at MedImmune, although as Professor Emeritus he retains a small research laboratory at the University of Chicago investigating neuronal control of metabolic homeostasis. 

Dr. Rhodes has received many awards for his diabetes research. He has been a regular member of important diabetes research grant review committees including the NIH, JDRF and ADA, as well as being on the Editorial Board of key scientific journals. He was also Chair of the ADA Council for Molecular, Cellular & Biochemical Aspects of Diabetes and Chair of the Medical and Scientific Review Committees at the JDRF 2005-2007. He is currently Chair of the International Board for the Danish Diabetes Academy. He has sat on many academic and industry scientific advisory boards in the area of diabetes/obesity drug development, and to develop new areas of diabetes research and advocacy.